Concepedia
Statistics
Publications
5
Citations
1.3K
H-Index
Active since
2020
Affiliations
Lancaster University(Current)
University of Nottingham
University of Cambridge
Roslin Institute
Oxford University Hospitals NHS Trust
Roudi Bachar is an author at Lancaster University specializing in pharmacotherapy, primary outcome analysis, and 28-day mortality.
Publications per year
2020–2023
Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 521 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +11
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2022 · 384 citations · Full text
Life Sciences, Immunology, Pharmacotherapy +14
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2021 · 291 citations · Full text
Pharmacy, Internal Medicine, Pharmacotherapy +13
Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial
Obbina Abani, Ali Abbas, Fatima Abbas et al. · The Lancet · 2023 · 132 citations · Full text
Medicine, Internal Medicine, Pharmacotherapy +17
Blinding practices during acute point-of-care ultrasound research: the BLIND-US meta-research study
Ross Prager, Kay Wu, Roudi Bachar et al. · BMJ evidence-based medicine · 2020 · 13 citations
Medicine, Anesthesiology, Emergency Medicine +17
1–5 of 5